Global Single-use Pump Market Size, Trend & Opportunity Analysis Report, by Product (Equipment, Accessories), Material (Polypropylene (PP) Pumps, Polyethene (PE) Pumps), and Forecast, 2025-2035
Global Single-use Pump Market Size, Opportunity Analysis and Forecast, 2025-2035
Market Definition and Introduction
The Global Single-Use Pump Market was valued at USD 486.8 million in 2024 and is anticipated to reach USD 1,926.29 million by 2035, expanding at a CAGR of 13.23% during the forecast period 2025-2035. As industries continue to move into more agile and sterile, and efficient production frameworks, single-use pumps have cropped up as essential enablers of optimisation in the process of biopharmaceutical production, modern laboratories and highly regulated fluid-handling environments. They opened ways for innovations whereby, even with requirements for sterility along with minimum risks of cross-contamination by the elimination of costly cleaning validation procedures, work processes have changed across diverse applications in life sciences. Bioprocess pipelines are beginning to depend more and more upon modularity and scalability with rapid turnaround times; thus, the adoption of pumping systems based on single-use technologies has been greatly enhanced in companies that are keen to strike a balance between compliance and productivity.
Avant-garde in single-use pump adoption is the pharmaceutical sector, one that, by virtue of precision and purity, defines its dimensions of operational success. By allowing that smooth transfer of fluid from upstream to downstream processing while maintaining compliance with the stringent regulations, especially current good manufacturing practices (cGMP), these systems have ushered in abundance, especially from the numerous biologics and cell- and gene-therapy pipelines that have precipitated a rethinking of traditional stainless-steel infrastructures progressively into flexible, disposable alternatives. While CDMOs are also focusing a bit on investments in single-use pump technologies to offer quicker turnaround and multiproduct facilities to their clients, this trend has been gaining momentum.
Beyond the health care and pharmaceutical industries, the single-use pump adoption trend is penetrating food and beverage, chemicals, and cosmetic sectors, which demand increased process safety given their sensitivity to contamination and wide product diversity. Furthermore, the environmental sustainability shift that many manufacturers are now adopting can give a further boost in attracting users, given that by implementing single-use systems, they will cut down on water and energy consumption associated with cleaning-in-place (CIP). This wakes up the industry from sleep and makes the single-use pump market a strategic focus for innovation and investment, owing to this increasing convergence of operational efficiency, regulatory compliance, and environmental stewardship.
Recent Developments in the Industry
- In January 1, 2024, exercise its brand new assortment of peristaltic pumps that are disposable, single-use, which are specially designed and engineered to provide enhanced evidence for sterility. The rollout of this system is very intense for giving support during rapid scale-up concerning biologics and gene therapy production, and, on the other hand, facilitating a reduction in cross-contamination risks with at least, while making all of this achievable with limited downtime. It is the continuing manifestation as far as the company aligning itself with calls from the industry's end, which is looking at modular, plug-and-play type bioprocessing systems.
- In June 2023, Levitronix launched a product line of magnetically levitated peristaltic single-use pumps in response to the unique needs of life sciences applications that require no mechanical wear and virtually no particle generation. Such pumps ensure the smoothest ultra-clean handling of fluids while extending longevity for real innovations with relevance to continuous manufacturing environments. By minimising contamination risks, Levitronix becomes the frontrunner in disposable pump technologies for critical use cases.
- In March 2025, Verder Group announced strategic investments to bolster production capacity for single-use pumps within the Europe and Asia-Pacific regions. This initiative is expected to loop supply resilience into the anticipated growth in demand from the global pharmaceutical and biotechnology sectors. By setting up localised hubs, Verder is aiming to diminish logistics bottlenecks and to achieve faster deployment of customised disposable solutions for emerging regional markets.
Market Dynamics
Biopharma growth and increasing biologics pipeline drive robust adoption of single-use pumping systems.
The inexorable rise of biologics, vaccines, and cell-based therapies has positioned single-use pumps as a critical enabler of biopharmaceutical manufacturing. Their role in safeguarding sterility, supporting multiproduct facilities, and accelerating turnaround times has made them indispensable to industry leaders. By eliminating the costs and delays of cleaning and validation, single-use pumps facilitate leaner, more adaptable operations that align with the sector-s fast-evolving product cycles.
Stringent regulatory frameworks fuel innovation in sterile fluid transfer solutions.
Global health authorities, including the FDA and EMA, continue to enforce rigorous standards around contamination control and sterility in manufacturing. These requirements have incentivised pump manufacturers to innovate disposable solutions that ensure compliance while streamlining production. The ability of single-use pumps to provide validated sterility assurance, especially within cGMP environments, has created a strong tailwind for their adoption. Manufacturers are increasingly investing in R&D to deliver pump systems with traceability, improved flow accuracy, and superior material compatibility.
Operational efficiency and cost advantages support wider cross-industry uptake.
By reducing downtime, cleaning validation, and resource consumption, single-use pumps deliver tangible cost and efficiency benefits. In industries such as food and beverage or cosmetics, where product diversity necessitates frequent batch changes, the elimination of lengthy sterilisation cycles provides a competitive edge. Furthermore, the rising preference for decentralised and flexible production systems underscores the relevance of disposable pumps across multiple verticals.
Supply chain volatility and waste management challenges present hurdles to adoption.
Despite strong growth prospects, the single-use pump industry faces challenges linked to supply chain instability and sustainability concerns. Material shortages, particularly of specialised polymers, may impact production costs and availability. Additionally, the disposal of single-use components remains a concern for companies seeking to balance sterility assurance with environmental responsibility. To address this, industry players are exploring recycling programmes, advanced materials, and closed-loop waste solutions.
Digitalisation and automation create new opportunities for pump customisation and process integration.
As industries move toward smart manufacturing, there is a rising demand for pumps that integrate seamlessly with process analytical technologies (PAT) and digital monitoring platforms. Manufacturers are increasingly embedding IoT-enabled sensors into single-use systems, enabling real-time flow control, predictive maintenance, and enhanced data integrity. This digital evolution is redefining the pump market by aligning disposable technologies with the broader Industry 4.0 landscape.
Attractive Opportunities in the Market
- Biopharma Expansion Surge - Increasing biologics and vaccine demand accelerates adoption of disposable pump solutions worldwide.
- Regulatory Compliance Edge - Stricter cGMP guidelines drive innovation in sterile, validated fluid transfer systems.
- R&D-Driven Customisation - Tailor-made single-use pump solutions meet niche needs across bioprocessing and laboratory applications.
- Eco-Sustainability Focus - Growing investments in recyclable polymers and closed-loop waste reduction initiatives strengthen market appeal.
- Asia-Pacific Manufacturing Boom - Expanding pharma infrastructure in China and India fuels disposable pump demand.
- Automation Integration Trend - IoT-enabled pumps create opportunities in real-time monitoring and digital process optimisation.
- Contract Manufacturing Growth - CDMOs adopting disposable technologies to offer flexible, multiproduct production capacities.
- Food and Beverage Uptake - Rising product diversity and hygiene concerns increase disposable pump adoption in food sectors.
- Strategic M&A Momentum - Consolidation in the pump industry enables accelerated innovation and market expansion.
- Next-Gen Polymer Development - Advanced materials with superior chemical resistance drive performance improvements in disposable pumps.
Report Segmentation
By Product: Equipment, Accessories
By Material: Polypropylene (PP) Pumps, Polyethene (PE) Pumps
By Region: North America (U.S., Canada, Mexico), Europe (UK, Germany, France, Spain, Italy, Spain, Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South Korea, Rest of Asia-Pacific), LAMEA (Brazil, Argentina, UAE, Saudi Arabia (KSA), Africa Rest of Latin America)
Key Market Players: Watson-Marlow Fluid Technology Group, Levitronix, PSG Dover, Almatec, Quantex Arc Ltd, Cole-Parmer, Saint-Gobain Life Sciences, Verder Group, Masterflex, and Entegris Inc.
Report Aspects
Base Year: 2024
Historic Years: 2022, 2023, 2024
Forecast Period: 2024-2035
Report Pages: 293
Dominating Segments
The equipment segment has the biggest share in the single-use pump market, as these are indispensable in biopharmaceutical production applications.
Equipment comprises the bulk of single-use pump sales under the global market segment, as these systems are needed in biopharma for making sterile, precise, and scalable fluid handling operations. For instance, peristaltic and centrifugal pumps are at the heart of both upstream and downstream processes, yet take away cross-contamination risk and operational downtime. As a biopharma manufacturer diversifies into biologics, cell therapies, and vaccines, the equipment sub-segment constitutes the backbone of flexible and multiproduct production facilities. Moreover, as the design of pumps rapidly advances regarding better flow accuracy, single-use assemblies, and IoT-enabled monitoring, their dominance gets entrenched. The stronger alignment of equipment with the best practices cGMP standards in the industry additionally guarantees compliance with regulations for the pharmaceutical company, thereby strengthening its stronghold in the market.
The PP pumps dominate the material segment on account of enhanced chemical resistance and versatility in application usage.
Among classes governed by material, the most commonly adopted genera are those pumps that contain polypropylene due to their high chemical resistance, lightweight nature, and applicability in a variety of bioprocessing fluids. They are used on a large scale in sterile production environments where purity and performance cannot be compromised. In addition, they are often much preferred in different applications from pharmaceutical, chemical, and food sectors because they last longer when handling corrosive or sensitive fluids. Advances in polymer engineering have produced the PP pumps with higher pressure tolerance and performance capabilities in terms of flow stability. With manufacturing industries increasingly looking to single-use solutions that hopefully will cost a little less, PP pumps seem to be the best mix between high performance and low price. This successful formula placed them in a leading position above all other materials, even polyethene, in the most demanding applications.
Pharmaceutical and biopharmaceutical industries remain the fastest-growing application base for single-use pumps worldwide.
Single-use pump technologies continue to establish themselves in the pharmaceutical sector due to precision, sterility, and compliance requirements. From upstream bioprocessing to the final formulation stage, these pumps ensure that liquid is safely, sterilely, and efficiently transferred, which has a direct impact on drug quality and subsequently patient safety. The area heading straight into biologics, cell-based therapies, and personalised medicine underlines the need for these disposable systems, allowing rapid changeovers and multiproduct capabilities. CDMOs carry this further by adopting those technologies to enhance capacity and flexibility. Regulatory pressure concerning validated sterility profiles eventually drives single-use systems as the option of choice within the industry rather than stainless steel infrastructure. This deflation accelerates momentum so that pharmaceutical applications will be the primary market expansion driver within a decade.
Key Takeaways
- Pharma Drives Growth - Biopharma and personalised medicine accelerate demand for sterile, disposable pump solutions.
- Equipment Dominance - Core pumping systems lead market adoption with scalable, regulatory-compliant solutions.
- Polypropylene Leadership - PP pumps outpace alternatives with superior durability and chemical resistance.
- Biologics Expansion - Increasing global biologics pipelines drive heavy uptake of disposable fluid handling systems.
- Automation Alignment - IoT-enabled pumps integrate with Industry 4.0 for enhanced process optimisation.
- Asia-Pacific Momentum - Manufacturing expansion in India and China accelerates regional pump adoption.
- Sustainability Challenge - Waste management remains a hurdle, pushing innovation in recyclable materials.
- CDMO Adoption Surge - Contract manufacturers expand flexible facilities using disposable pumping technologies.
- Regulatory Tailwinds - Stricter FDA and EMA sterility guidelines boost innovation in single-use pump design.
- Cross-Industry Applications - Food, chemical, and cosmetic sectors increasingly adopt pumps for contamination-sensitive workflows.
Regional Insights
North America will dominate the global single-use pump market thanks to its strong biopharmaceutical infrastructure and regulation-driven innovations.
North America, especially the US, has a large impact on the global single-use pump market due to its good biopharma ecosystem, strong regulatory frameworks, and large R&D investments. The biologics pipeline and vaccine development initiatives in the region have created a demand for sterile, disposable pumping systems that mitigate contamination risk and enhance speed of production. Further, the stringent FDA regulations for contamination control and cGMP compliance have pulled the market for advanced disposable solutions. The leading players in the market, Watson-Marlow and Saint-Gobain, have a considerable manufacturing and innovation footprint across North America, which aids further in establishing North American dominance.
Europe is driving eco-friendly disposable pump innovations and modular bioprocessing technologies.
Europe is carving for itself a niche in sustainable manufacturing practices for the single-use pump industry. The manufacturing ecosystem for pumps has now moved towards eco-friendly materials, energy-efficient and waste-reducing designs under the stringent directive of EU regulations and environmental policies. Germany, the UK, and France have developed as innovation hotspots that harbour advanced bioprocessing facilities highly reliant on disposable fluid-handling systems. Furthermore, the EU has taken strong regenerative chemistry, and circular economy initiatives have fuelled companies to reformulate and redesign pumps to improve sustainability without compromising their sterility or performance. Europe remains the continent with the foresightful regulatory framework aligned with industry demand, putting it at the forefront of eco-friendly disposable pump adoption.
Asia-Pacific is emerging as the fastest-growing single-use pump market, propelled by industrialisation and pharmaceutical growth.
The Asia-Pacific region is expected to register the highest growth rate in the global single-use pump market, fueled by increasing investments in pharmaceutical manufacturing and expanding healthcare infrastructure. China and India, with their massive biologics and vaccine production capacity, are set to demand disposable pump technologies. Adoption has further been invigorated by the encouragement of cleaner, modular manufacturing systems from local governments. Additionally, the growing base of CDMOs and CROs in the region has greatly invested in disposable systems for flexibility and global compliance requirements. South Korea and Japan also remain key hubs of innovation, integrating advanced polymer technologies into the next-generation disposable pumps. With rapid industrialisation and a booming healthcare sector, the Asia-Pacific is set to spearhead global demand in the forecast period.
Leveraging upcoming healthcare infrastructures and diversifying industries, the LAMEA region is fast embracing opportunities to enhance pump adoption.
The LAMEA region is slowly finding its way into the single-use pump market, and a framework is being sculpted by increasing pharmaceutical
manufacturing in Brazil, Argentina, and Saudi Arabia. The adoption of disposable pumping solutions is being fast-tracked by the Middle East's increasing investments in biotechnology hubs as well as Africa's improving healthcare infrastructure. While the region does have logistical difficulties and lower regulatory harmonisation compared to North America and Europe, it remains a potential area to tap into, especially as the local industries tend to diversify into life sciences, food, and speciality chemicals. Multinational players are increasingly seeking local partnerships and manufacturing hubs to service the opportunities for growth that exist in LAMEA's fragmented yet promising ecosystem.
Key Benefits for Stakeholders
- The report offers a quantitative assessment of market segments, emerging trends, projections, and market dynamics for the period 2024 to 2035.
- The report presents comprehensive market research, including insights into key growth drivers, challenges, and potential opportunities.
- Porter's Five Forces analysis evaluates the influence of buyers and suppliers, helping stakeholders make strategic, profit-driven decisions and strengthen their supplier-buyer relationships.
- A detailed examination of market segmentation helps identify existing and emerging opportunities.
- Key countries within each region are analysed based on their revenue contributions to the overall market.
- The positioning of market players enables effective benchmarking and provides clarity on their current standing within the industry.
- The report covers regional and global market trends, major players, key segments, application areas, and strategies for market expansion.
Frequently Asked Question(FAQ) :
The pharmaceutical and biopharmaceutical sectors are the leading drivers of the market. The rise of biologics, vaccines, and cell- and gene-therapy pipelines necessitates the precision, sterility, and contamination control that single-use pumps provide, allowing for a shift away from traditional stainless-steel infrastructures.
Polypropylene pumps lead the market due to their superior chemical resistance, lightweight nature, and versatility across various bioprocessing fluids. They offer an ideal balance between high performance and cost-effectiveness, particularly in demanding sterile production environments.
While they are disposable, single-use pumps contribute to sustainability by significantly reducing the water and energy consumption typically required for Cleaning-in-Place (CIP) and Steam-in-Place (SIP) procedures. Additionally, the industry is increasingly investing in recyclable polymers and closed-loop waste solutions to mitigate plastic waste concerns.
The primary advantages include the elimination of costly and time-consuming cleaning validation procedures, a significantly reduced risk of cross-contamination, faster turnaround times between batches, and increased modularity for multi-product facilities.
North America dominates the market due to its advanced biopharmaceutical infrastructure, high levels of R&D investment, and a stringent regulatory environment enforced by the FDA. Major industry players like Watson-Marlow and Saint-Gobain also maintain a significant manufacturing presence in this region.
The Asia-Pacific region is set to be the fastest-growing market. This growth is fueled by massive investments in pharmaceutical manufacturing in China and India, the expansion of healthcare infrastructure, and a surging number of Contract Development and Manufacturing Organizations (CDMOs) adopting flexible technologies.
The industry is moving toward "Smart Manufacturing" by integrating IoT-enabled sensors into pump systems. This allows for real-time flow control, predictive maintenance, and enhanced data integrity, aligning disposable technologies with the broader Industry 4.0 landscape.
Key hurdles include supply chain volatility—specifically shortages of specialized polymers—and the environmental challenge of disposing of single-use plastic components. Additionally, the high initial cost compared to some alternatives and the complexity of digital integration can present barriers to entry.
Key market participants include Watson-Marlow Fluid Technology Group, Levitronix, PSG Dover, Almatec, Quantex Arc Ltd, Cole-Parmer, Saint-Gobain Life Sciences, Verder Group, Masterflex, and Entegris Inc. Recent strategic moves, such as Levitronix’s launch of magnetically levitated pumps and Verder Group’s production expansion, highlight the competitive nature of the sector.
